Home
Company Profile
Mission Statement
Meeting the Bottleneck Challenge
Corporate Profile
News & Press Releases
Meetings and Events
FAQs
Meet Our Team
Careers
Job Search
Why Avid Bioservices
Contact Us
Driving Directions
Contract Management
Our Commitment To Aligning Objectives
Partnering With Your Company
Project Proposal
Project Management Steps
Manufacturing Capability
Tustin Ca. Facility
Bioreactors and Equipment
Master and Working Cell Bank
Protein Characterization and Purification
Process Sciences
Benefits of Process Development
Bioreactor Process Development
Protein Purification Process Development
Cell Line Optimization Services
Assay Development
Quality Systems
Quality System
Quality Assurance
Quality Control
Compliance
Regulatory
Product Characterization
Latest News
Apr 2, 2008
New Downstream Publication: Purification of IgM Monoclonal Antibodies
Dec 5, 2007
Avid Bioservices to Manufacture Lead Cancer Stem Cell Antibody for ARIUS
Dec 19, 2006
Avid Bioservices and Halozyme Therapeutics Extend Commercial Manufacturing Agreement
Dec 6, 2005
Peregrine's Subsidiary Begins First Commercial Stage Drug Manufacturing Project
Nov 22, 2005
Peregrine's Manufacturing Subsidiary Announces Bioproduction Contract With Major Leading Cancer Center
Oct 20, 2005
PEREGRINE PHARMACEUTICALS' AVID BIOSERVICES AWARDED CONTRACT TO PRODUCE CLINICAL PHASE ANTIBODY
Sep 20, 2005
AVID BIOSERVICES AND BIORELIANCE TEAM UP TO PROVIDE EUKARYOTIC CELL BANKING SERVICES TO THE BIOPHARMACEUTICAL INDUSTRY
Feb 17, 2005
Avid Bioservices Signs Commercial Manufacturing Contract with Halozyme Therapeutics
Oct 14, 2004
Avid Bioservices Expands Manufacturing Capacity
Dec 8, 2003
Avid Bioservices To Expand Manufacturing Capacity - 1000L Working Volume Bioreactor to be Operational by July 2004
Nov 24, 2003
Avid Bioservices Signs Manufacturing Supply Agreement For Production Of Recombinant Protein
Nov 18, 2003
Avid Bioservices Signs Product Development Agreement With Medipharm Biotech For Tumor Necrosis Therapy
Oct 29, 2003
Avid Bioservices Signs Manufacturing Supply Agreement For Production Of Monoclonal Antibodies
Apr 2, 2003
AVID BIOSERVICES SIGNS MANUFACTURING SUPPLY AGREEMENT FOR THE PRODUCTION OF FOUR MONOCLONAL ANTIBODIES
Mar 14, 2003
AVID BIOSERVICES AND INHIBITEX FINALIZE SUPPLY AGREEMENT FOR ADDITIONAL CGMP MANUFACTURING RUNS - Avid Completes Original Manufacturing Supply Agreement for Inhibitex
Nov 19, 2002
AVID BIOSERVICES PRESENTS AT IBC BIOPHARMACEUTICAL PRODUCTION WEEK CONFERENCE
Mar 13, 2002
AVID BIOSERVICES ANNOUNCES MANUFACTURING SUPPLY AGREEMENT FOR THE PRODUCTION OF A THERAPEUTIC MONOCLONAL ANTIBODY INTENDED FOR PHASE III CLINICAL TRIALS
Mar 6, 2002
AVID BIOSERVICES ENTERS INTO A MANUFACTURING AND SUPPLY AGREEMENT WITH SERADYN
[ Back ]
